Cyclopharm Osake

Cyclopharm EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Cyclopharm (CYC.AX) 17.8.2026 päivämäärällä on −13,04 M AUD. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli −7,66 M AUD — muutos 70,24 % (matalampi).

EBITDA

−13,04 MAUD

YoY

70,24%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Cyclopharm on 2026 −13,04 M AUD. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Cyclopharm oli 2025 −7,66 M AUD. Se laskee 70,24% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Cyclopharm Osakeanalyysi

Mitä Cyclopharm tekee? Cyclopharm Ltd is an Australian company that was founded in 1986 and has since been developing innovative medical solutions. The company operates in the field of nuclear medicine and focuses on providing diagnostic and therapeutic products and services. The history of Cyclopharm Ltd began with the development of the Technetium-99m generator, an instrument for generating radioisotopes that can be used in medical imaging. Since then, the company has expanded its offerings and now offers a wide range of products and services. Cyclopharm Ltd's business model is based on research and development of new solutions based on the needs of the medical community and patients. The company works closely with doctors, scientists, and other experts to ensure that its products and services meet the highest standards. Cyclopharm Ltd is divided into various divisions to coordinate and optimize its activities. These include diagnostics, therapy, research and development, as well as sales and marketing. Each division works closely with the others to ensure that the company achieves its goals and provides optimal customer care. Some of Cyclopharm Ltd's most well-known products include the Technetium-99m generator and the radiopharmaceutical Technegas. Technegas is a gas used for lung imaging and plays an important role in diagnosing lung problems. The radiopharmaceutical is produced using the Technetium-99m generator and is an important addition to medical imaging. In addition, Cyclopharm Ltd also develops therapeutic solutions that can be used to treat cancer and other diseases. These include radiopharmaceuticals used in radiation therapy, as well as other solutions tailored to the individual needs of patients. Cyclopharm Ltd is also actively working on improving and expanding its products and services. The company invests in research and development to develop innovative solutions that can improve medical imaging and therapy. Additionally, the company works closely with its customers to better understand their needs and offer them tailored solutions. Overall, Cyclopharm Ltd is an innovative and goal-oriented company that focuses on providing diagnostic and therapeutic solutions in the field of nuclear medicine. The company has a long history of leadership in this field and will continue to be at the forefront of developing solutions that improve the lives of patients and medical professionals. Cyclopharm on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Cyclopharm osakkeesta

Yhtiön Cyclopharm EBITDA (Tulos ennen korkoja, veroja ja poistoja) on −13,04 M AUD vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Cyclopharm muuttui arvosta −7,66 M AUD arvoon −13,04 M AUD, mikä edustaa 70,24 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Cyclopharm:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n AUD on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Cyclopharm historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Cyclopharm

Kaikki tunnusluvut — Cyclopharm